FOXP1 recognizes regulatory DNA and acts with transcriptional partners in the nucleus. Human full-length repression, the 431–559 DNA-binding fragment and SMRT recruitment support the repressor core (PMID:15286807(https://pmc.ncbi.nlm.nih.gov/articles/PMC484980/), PMID:18347093(https://pmc.ncbi.nlm.nih.gov/articles/PMC2275427/), PMID:20950788(https://pmc.ncbi.nlm.nih.gov/articles/PMC2978954/)). Its output depends on context: human FBXL7 activation and the altered DNA preference and pluripotency-associated regulation of FOXP1-ES are retained (PMID:28218735(https://pubmed.ncbi.nlm.nih.gov/28218735/), PMID:21924763(https://pubmed.ncbi.nlm.nih.gov/21924763/)). This is not a claim that every product or target behaves identically.
The original proteomic Table S6 establishes FOXP1 association with FOXP2 and FOXP4 in chromatin and soluble fractions. Chromatin supports nuclear association; soluble recovery does not independently locate the complex in the nucleus. Self entries marked Bait are not homomerization measurements. Independent cellular co-IP and BRET support the partner and self-association judgments without proving isolated binary affinity or native stoichiometry (PMID:25609649, Table S6, PMID:25027557(https://pubmed.ncbi.nlm.nih.gov/25027557/), PMID:26647308(https://pubmed.ncbi.nlm.nih.gov/26647308/)).
Human vascular and B-cell experiments support context-dependent migration, proliferation and survival. Human FOXP1 expressed in a mouse macrophage model is distinguished from a mouse-protein assay, and each cytokine endpoint is evaluated separately. Mouse Foxp1 loss increases IL21 and follicular-helper differentiation, supporting the bounded direction corrections while preserving the original human transfer and donor records (PMID:24023716(https://pmc.ncbi.nlm.nih.gov/articles/PMC3759435/), PMID:25267198(https://pmc.ncbi.nlm.nih.gov/articles/PMC4246697/), PMID:18799727(https://pmc.ncbi.nlm.nih.gov/articles/PMC2597137/), PMID:24859450(https://pmc.ncbi.nlm.nih.gov/articles/PMC4142638/)).
The five unresolved source contexts concern precise striatal/forebrain development, the TNF-response contribution, H2O2-triggered programmed death and CXCL2 production. Rat FOXP1 expression/localization does not by itself isolate process participation; H2O2 and chelerythrine endpoints, and CXCL2 versus MCP1/CCL2, remain separate. The newly available androgen study measures region-specific rat Foxp1 expression after DHT, while its AR co-IP tests Foxp2 (PMID:26333362(https://pmc.ncbi.nlm.nih.gov/articles/PMC4747867/), PMID:26842647(https://pmc.ncbi.nlm.nih.gov/articles/PMC5067638/), PMID:25247470(https://pmc.ncbi.nlm.nih.gov/articles/PMC4239422/)). Exact public locators and access limits are in the source guide.
Genuine acquisition yielded 79 raw contexts and 79 TSV rows, then the native seed reduced them to 74 keys. The private 77-context transfer restores three distinct nuclear-scope pairs as separate review rows. Both originals of each of the two remaining provenance-only duplicate pairs are retained. All 14 original extension atoms are preserved, including CD22 as input and the DNA-damage-response context; no scope is manufactured by joining two alternative records. The source evidence archives all originals and exact TSV/native-seed/candidate joins, with explicit indexing conventions.
The seven native product declarations are Q9H334-1, -3, -4, -5, -6, -7 and -8. Official individual sequences agree with VAR_SEQ reconstruction. The 114-aa product lacks the downstream forkhead region, but no untested function is assigned to it. Historical mouse A/D and human FOXP1D construct names are not silently mapped to current products. Experimental fragments and artificial disease variants remain distinct from natural products.
Thirty normal sources are now present, including seven immutable existing-main sources and twenty-three genuine acquisitions. All normal source bytes and the fetched UniProt/GOA files remain unedited. The draft has 36 references, 27 manual assessments and one core function. Its 77 proposed actions are 14 ACCEPT, 26 KEEP_AS_NON_CORE, 13 TOO_GENERAL, 19 MODIFY and 5 UNDECIDED; no NEW annotation or supporting quotation was added. Provider credentials remain on hold, so manual primary research supplies the literature evidence without a new provider attempt or fabricated provider output. Canonical authoring, history and local validation remain pending review of this private transfer.
The preceding preparation record is retained. The reviewed 77-context representation is now applied to the genuine seed, and a CREATE history records the session. Local default validation passed with four intentional advisories: one supported generic-binding association and three broad developmental TOO_GENERAL judgments without an asserted is_a descendant. Strict GOA matching passed for the 77 review contexts, and the status audit confirmed DRAFT. The genuine CREATE history, private HTML rendering and local source-document links passed. All 79 originals, 14 extension atoms, seven native products and 30 normal source hashes remain exact; the 56 protected prior objects, 41 scratch files and 16 prior branch tips are preserved. Full PR review, CI and actual integration remain pending.
Osteoclast development, animal organ development and system development remain supported non-core contexts. Their earlier TOO_GENERAL judgments lacked an asserted narrower term that entailed them, so those three actions are now KEEP_AS_NON_CORE. All original fields, evidence, other judgments and the molecular core are unchanged. The 77 review totals are now 14 ACCEPT, 29 KEEP_AS_NON_CORE, 10 TOO_GENERAL, 19 MODIFY and 5 UNDECIDED. Updated scoped checks are pending.
Updated default validation passes with one advisory for the supported generic-binding association. Strict GOA matching passes for all 77 review contexts, and the status audit confirms DRAFT. The three developmental action advisories are resolved by retaining those supported contexts as non-core. No original source object, extension, product, core function or other annotation judgment changed. Full PR review and integration checks remain pending. The earlier preparation and initial check entries above are retained as session history; the current totals are 14 ACCEPT, 29 KEEP_AS_NON_CORE, 10 TOO_GENERAL, 19 MODIFY and 5 UNDECIDED.
AURKA association now uses protein kinase binding, and the FBXL7 reporter evidence is represented by positive regulation of Pol II transcription. These refinements preserve cellular association, promoter-region and context-dependent output limits (PMID:28218735(https://pmc.ncbi.nlm.nih.gov/articles/PMC5337621/)). The existing core description explicitly includes sequence-specific cis-regulatory DNA recognition. Raw-index bookkeeping was removed from biological reasons; complete provenance and distinct nuclear scopes remain in the source evidence.
Two genuinely acquired developmental papers provide independent functional support for the previously unresolved striatum and forebrain terms, which are now non-core. Mouse Nestin-Cre and Emx1-Cre experiments remain distinct from the original rat IEP transfers and from endogenous human necessity. The earlier two-source access limits remain documented (PMID:25266127(https://pmc.ncbi.nlm.nih.gov/articles/PMC4419151/), PMID:29138280(https://pmc.ncbi.nlm.nih.gov/articles/PMC5733496/)). The proposed negative-regulation-of-T-follicular-helper-differentiation term records an ontology gap without adding an annotation (PMID:24859450(https://pmc.ncbi.nlm.nih.gov/articles/PMC4142638/)).
The twelve PMID:18799727 process contexts retain eleven non-core judgments and one unresolved CXCL2 judgment. The nonsignificant Table 3 in-vitro TNF-alpha comparison is not used as confirmation; the separate c-Fms rescue supports the bounded TNF-regulation context. The Figure 6D control identities are recorded without inferring an uninspected control's quantitative outcome (PMID:18799727(https://pmc.ncbi.nlm.nih.gov/articles/PMC2597137/)).
Current totals are 14 ACCEPT, 30 KEEP_AS_NON_CORE, 9 TOO_GENERAL, 21 MODIFY and 3 UNDECIDED across the same 77 contexts. All 79 originals, 14 extension atoms, seven products and original source fields remain intact. There are now 38 references, 29 manual assessments and 32 immutable normal sources. No quotation, NEW annotation or provider run was added. Follow-up application and scoped-check outcomes will be recorded after execution; previous notes and history are preserved.
Default validation passes with zero annotation advisories. Strict GOA matching passes for all 77 review contexts. The status audit identified the previous DRAFT value; the computed COMPLETE status was applied as the only subsequent YAML change and the audit then passed. The initial status diagnostic remains in the check record. All source-specific uncertainties remain explicit; COMPLETE is the validation status, not a claim that every biological question is settled. The earlier preparation and initial-publication entries remain unchanged. The two new developmental sources were genuinely fetched without force, and all prior source bytes remain preserved.